No abstract

No abstract

Tau in Alzheimer disease brain is highly phosphorylated and aggregated into paired helical filaments comprising characteristic neurofibrillary tangles. Here we have analyzed insoluble Tau (PHF-tau) extracted from Alzheimer brain by mass spectrometry and identified 11 novel phosphorylation sites, 10 of which were assigned unambiguously to specific amino acid residues. This brings the number of directly identified sites in PHFtau to 39, with an additional six sites indicated by reactivity with phosphospecific antibodies to Tau. We also identified five new phosphorylation sites in soluble Tau from control adult human brain, bringing the total number of reported sites to nine. To assess which kinases might be responsible for Tau phosphorylation, we used mass spectrometry to determine which sites were phosphorylated in vitro by several kinases. Casein kinase 1␦ and glycogen synthase kinase-3␤ were each found to phosphorylate numerous sites, and each kinase phosphorylated at least 15 sites that are also phosphorylated in PHF-tau from Alzheimer brain. A combination of casein kinase 1␦ and glycogen synthase kinase-3␤ activities could account for over three-quarters of the serine/threonine phosphorylation sites identified in PHF-tau, indicating that casein kinase 1␦ may have a role, together with glycogen synthase kinase-

No abstract

Paired helical filaments (PHFs) are the structural constituents of neurofibrillary tangles in Alzheimer's disease and are composed of hyperphosphorylated forms of the microtubule‐associated protein tau (PHF‐tau). Pathological hyperphosphorylation of tau is believed to be an important contributor to the destabilisation of microtubules and their subsequent disappearance from tangle‐bearing neurons in Alzheimer's disease, making elucidation of the mechanisms that regulate tau phosphorylation an important research goal. Thus, it is essential to identify, preferably by direct sequencing, all of the sites in PHF‐tau that are phosphorylated, a task that is incomplete because of the difficulty to date of purifying insoluble PHF‐tau to homogeneity and in sufficient quantities for structural analysis. Here we describe the solubilisation of PHF‐tau followed by its purification by Mono Q chromatography and reversed‐phase HPLC. Phosphopeptides from proteolytically digested PHF‐tau were sequenced by nanoelectrospray mass spectrometry. We identified 22 phosphorylation sites in PHF‐tau, including five sites not previously identified. The combination of our new data with previous reports shows that PHF‐tau can be phosphorylated on at least 25 different sites.